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Conclusions: In this large pilot experience, rates of ischemic and bleeding events 
trended lower with bivalirudin than with heparin during contemporary PCI. Bivalirudin 
may be the first antithrcmbctic agent to uncouple suppression of ischemic events from 
hemorrhagic risk. 
1053-4 Reduction in Percutaneous Coronary Intervention- 
Related Bleeding With Bivalirudin Is Particularly 
Striking in Women 
&s&&&v&, Leslie Cho. A. Michael Linccff, John A. Bittl. Eric J. Tcpol, Cleveland 
Clinic Foundation, Cleveland, Ohio, Ocala Heart Institufe, Ocala, Florida. 
Background: Female gender is a known potent risk factor for post-procedural bleeding 
among patients undergoing percutaneous coronary intervention (PCI). 
Methods: Within a randomized clinical trial of coronary angioplasty comparing bivalirudin 
to unfractionated heparin (the Bivalirudin Angioplasty Trial), rates of ischemic events and 
major hemorrhage were stratified by gender. 
Results: of the 4312 patients enrolled. 1367 (32.2%) patients were women. Compared 
to males, female gender was associated with a 2.3-fold increased risk of major hemor- 
rhage - males: 131/2925 (4.5%) YS females: 144/1367 (10.4%) (pc0.0001). When strati- 
fied by treatment arm, bivalirudin was associated with a significant reduction in bleeding 
regardless of gender. However, this effect was most striking among female patients 
(Table). Considering a combined safety and efficacy endpoint of death, MI, revasculariza- 
tion. and major hemorrhage. bivalirudin was associated with a 50% relative risk reduction 
in adverse events in wcmen _ 141/690 (20.4%) vs 69/697 (9.9%) (p~O.OOOl), and a 35% 
relative risk reduction in men - 171/1461 (11.7%) vs Ill/l464 (7.6%) (p<O.WOl). 
Conclusions: Bivalirudin is associated with a substantial reduction in bleeding and 
ischemic events in both men and women. but the improved safety profile is especially 
prominent among women. Such patients with an increased risk of bleeding during PCI 
may benefit if bivalirudin is used in place of unfractionated heparin. 
Major Hemorrhage 
Heparin Bivalirudin P Value 
Women 
Men 
(I 07/690) 15.5% (37/697) 5.3% <0.@301 
(92/1461) 6.3% (39/1464) 2.7% <O.OOOl 
1053-5 A New Rapid Ecarin Clotting Time Assay but Not 
Activated Clotting Time Strongly Correlates With 
Blvallrudln Concentration: A Percutaneous Coronary 
Intervention Study 
mCho, Joel Reginelli, A. Michael Linccff, Marco Roffi, Teresa Kaldus, Kandice 
Kottke-Marchant, Patrick D. Mize, David J. Moliterno. The Cleveland Clinic Foundation, 
Cleveland, Ohio, Pharrnanetics Inc, Chapel Hi//, Ohio. 
Background: Recently, direct thrombin inhibitors (DTI) have been approved for antico- 
agulation in percutaneous coronary interventions (PCI). The accuracy of the activated 
clotting time (ACT), used for monitoring heparin. is uncertain for patients receiving DTI. A 
new point-of-care assay has been developed based on the ecarin clotting time (ECT), 
which specifically measures the activity of direct thrombin inhibitors. No prior study has 
evaluated the correlation of ECT and ACT to the direct measurement of anti Factor Ila 
activity duirng PCI. Methods: To test the accuracy of available ACT assays (Hemcchrcn 
and Pro-DM) and the rapid ECT assay (Pharmanetics), we enrolled 64 consecutive PCI 
patients receiving the DTI bivalirudin at The Cleveland Clinic. We compared point of care 
ACT and ECT to central laboratory anti Factor Ila activity levels, Anti Factor Ila activity is 
a direct measurement of bivalirudin concentration in body. Samples were tested in both 
titrated and non-titrated blood. Correlation coefficient was calculated by the Spearman 
test. Results: Bivalirudin concentration correlated well with ECT sample (rxO.76, 
p<O.OOl). In contrast, there was relatively poor correlation between bivalirudin concentra- 
tion and Hemcchrcn ACT (r=0.26, p=O.O5) or pro-DM ACT (wO.41, p<O.OOl). There was 
alsc poor correlation between ECT and Hemcchrcn ACT (r&27. p=O.O4) and ECT with 
pro-DM ACT (r=O.52, p<O.601). There was poor correlation between pro-DM ACT and 
Hemwhron ACT (w0.40. p=O.O02). Conclusion: ECT is a reliable measurement of anti- 
coagulation in patients receiving bivalirudin, while ACT has poor correlation with bivaliru- 
din concentration. Additionally there is poor correlation between ACT and ECT in such 
patients. These findings have important implications for guiding the extent of anticoagula- 
tion during PCI with DTI. 
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1054-13 Smoking, Thrombus, and Plaque in the Culprit Vessel In 
Patients With Acute Myocardlal Infarction: Angioscopic 
Findings 
Ipshiva Kurctobi, Atsushi Hirayama, Yasunori Ueda, Masahiko Shimizu, Tcmohito 
Ohtani, Kazuhisa Kodama, Osaka Police Haspita/, Osaka, Japan. 
Backgrounds, Habitual smoking is paradoxically associated with good prognosis in 
patients with acute myccardial infarction (AMI), and results in the higher successful 
thrombolytic therapy. Therefore, we investigated the hypothesis that smoking status is 
closely associated with amount of thrcmbus culprit lesion. Methods, The prevalence of 
plaques and amount of thrombus in the major coronary arteries were successfully evalu- 
ated in 62 patients (male: 55, mean age: 60.2). All patients were underwent percutane- 
ous coronary intervention (PCI), and the residual amount of thrombus after PCI were 
semi-quantatively divided into 2 groups (massive: 1x33 or little: n=29) by angioscopy. 
Furthermore, we analyzed the color of plaque an culprit lesion (4 grades from white to 
yellow), and the number of plaque in infarct related artery (IRA). Results, 65% of the 
enrolled patients were current smokers. Although baseline TIMI grade was not signifi- 
cantly changed, prevalence of collateral vessels to infarcted related artery was higher in 
smoking patients, compared with non- smoking patients (45% VS. 17%. p=O.O9). The 
massive thrcmbus was higher prevalence in smoking patients, compared with non-smok- 
ing patients (65% vs. 22%, p<O.Ol). The number of plaque in IRA (3.012.0 vs. 3.3~1.6) 
max plaque score (2.7eO.9 vs. 2.7kO.9) and the color of plaque in culprit lesion (2.7kO.9 
vs. 2.6*1 .I) were not significantly affected by smoking status. As ccronaly risk factors, 
Total cholesterol (205 vs. 160 mg/dl, ~~0.05) and triglycelide (136 vs. 114 mg/dl. ~~0.05) 
were significantly higher, and the prevalence of hypertension (50% vs. 35, p<O.l) was 
significantly lower in smoking patients. Conclusion. This is first evidence to assess the 
association of smoking status and the amount of thrcmbus in culprit lesion directly, and 
also these findings may provide the explanation of the smoker’s paradox. 
1054-14 Possible Mechanism of Coronary Thrombosis Caused 
by Vasospasm In Angiographically Nearly Normal 
Coronary Artery: Evaluation by Plaque Appearance and 
Malondlaldehyde-Modified Oxidized LDL 
&&masa Tani, lkuyoshi Watanabe, Takeshi Fujii, Kazutoshi Ishikawa, Michiaki 
Matsumcto, Takeo Anazawa, Takashi Miyamoto, Ken Nagao, Katsuo Kanmatsuse, 
Department of Cardiobgy, Nihon University Surugadai Hospital, Tokyo, Japan, 2nd 
Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan. 
Background: Investigators have that demonstrated focal vascspasm has a high inci- 
dence of acute coronary syndrome(ACS) compared with diffuse vascspasm. Recently 
circulating malondialdehyde-modified oxidized LDL(MDA-LDL) was reponed to activate 
thrombus formation .Therefcre we investigated the differences in plaque appearance and 
plasma MDA-LDL between two patterns of vascspasm .Methcds and Results: Blood 
samples were collected from aortic rcct(Ao) and coronary sinus before provocation 
of left coronary spasm After relief of spasm, IVUS study was performed and volumetric 
analyses of spasm lesions were evaluated with Netra-3D IVUS system. More abundant 
soft plaque was localized just at the lesion with focal vascspasm even in the absence of 
significant angiographic disease, whereas in diffuse vascspasm, intimal thickness 
existed diffusely along the coronary arteries. Data is presented in TableConclusions: 
Plasma MDA-LDL levels associated with triggering thrombosis were significantly ele- 
vated in the coronary circulation in focal vascspasm. Under this condition, dramatically 
increased % plaque volume during focal vascccnstriction might play an important role in 
the mechanism of thrcmbogenicity leading to ACS 
Diffuse n=20 Focal n=l5 p value 
Cs-AC difference of MDA-LDL (U/L) -6.9+/-9.0 12+/-14.9 to.05 
Vessel volume(mm3) 127.7+/-39.1 134.4+/s44.0 ns 
Lumen volume(mm3) 91.3+/-11.2 79.5+/-10.6 ns 
Plaque vclume(mm3) 30.6+/-10.2 55.2+/-10.3 <0.05 
% plaque volume(plaque volume/vessel volume) 23.9+/-9.2 40.2+/-9.6 co.05 
1054-I 5 Insulin Resistance as an Independent Predictor of 
Acute Coronary Syndrome: An Intravascular Ultrasound 
Study With Clinical Correlations 
Takashi Yoshitama. Masato Nakamura. Tan, Tsunoda, Ycko Kitagawa, Masanori Shiba, 
Suguru Yajima, Masamichi Wada. Raisuke lijima, Rintam Nakajima. Takurc Takagi. 
Hitoshi Anzai. Takahirc Nishida, Tetsu Yamaguchi, Ohashi Hospital, Jcho University, 
Tokyo, Japan. 
Background: Insulin resistance has been implicated as an important initiating factor in 
coronary atherosclerosis. However, asscciations between insulin resistance and acute 
coronary syndrome (ACS) remain unclear. 
Methods: Before intervention, 75 patients with 65 culprit lesions underwent intravascular 
ultrasound (IVUS) examination by which cross-sectional area (CSA) within the external 
elastic membrane (EEM), lumen CSA, and plaque CSA were evaluated. Positive remod- 
